• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms

tetano

Editor, Senior Moderator
Bing Du Xue Bao. 2012 Sep;28(5):572-6.
[Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
[Article in Chinese]
Huang L, Zhou JF, Wei H, Shu YL.
Source

World Health Organization Global Influenza Collaboration, Centre for Reference and Research, State Key Laboratory for Molecular Virology and Genetic Engineering, Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Beijing 102206, China. huanglan301@126.com
Abstract

Influenza viruses are highly contagious for human population and result in acute respiratory infectious diseases ranging from mild to severe. Neuraminidase (NA) inhibitors (NAIs) (oseltamivir, zanamivir, peramivir and laninamivir), which target the NA glycoproteins of influenza A and B viruses are widely used in the prophylaxis and treatment of influenza virus infection. However, the substitutions of amino acids in NA or HA gene may lead to resistances to NAIs. NAI-resistance-related substitutions are typically specific to certain NA type or subtype. The sensitivity for NAI-resistance detection is affected by different assays used.

PMID:
23233936
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23233936
 
Back
Top Bottom